$CRSP stock has now risen 8% today, according to our price data from Polygon. There has been approximately $54,230,206 of trading volume.
It has been the 627th most-searched ticker on Quiver Quantitative over the last day, out of 13,110 total tickers searched.
Here is what we see in our data on $CRSP (you can track the company live on Quiver's $CRSP stock page):
$CRSP Insider Trading Activity

$CRSP insiders have traded $CRSP stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $CRSP stock by insiders over the last 6 months:
- SAMARTH KULKARNI (Chief Executive Officer) has made 0 purchases and 7 sales selling 127,134 shares for an estimated $7,018,135.
- RAJU PRASAD (Chief Financial Officer) has made 0 purchases and 7 sales selling 78,249 shares for an estimated $4,541,338.
- JAMES R. KASINGER (General Counsel and Secretary) has made 0 purchases and 4 sales selling 11,544 shares for an estimated $574,239.
- NAIMISH PATEL (Chief Medical Officer) has made 0 purchases and 2 sales selling 6,936 shares for an estimated $362,596.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CRSP Hedge Fund Activity
We have seen 219 institutional investors add shares of $CRSP stock to their portfolio, and 148 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS added 4,725,037 shares (+inf%) to their portfolio in Q1 2026, for an estimated $224,770,010
- CAPITAL INTERNATIONAL INVESTORS removed 4,705,951 shares (-79.9%) from their portfolio in Q1 2026, for an estimated $223,862,089
- TWO SIGMA INVESTMENTS, LP added 1,012,430 shares (+215.1%) to their portfolio in Q1 2026, for an estimated $48,161,295
- UBS GROUP AG removed 761,614 shares (-30.2%) from their portfolio in Q1 2026, for an estimated $36,229,977
- SQUAREPOINT OPS LLC removed 427,533 shares (-73.6%) from their portfolio in Q1 2026, for an estimated $20,337,744
- DIMENSIONAL FUND ADVISORS LP removed 412,889 shares (-45.5%) from their portfolio in Q1 2026, for an estimated $19,641,129
- MILLENNIUM MANAGEMENT LLC added 346,686 shares (+1137.0%) to their portfolio in Q1 2026, for an estimated $16,491,853
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Quiver Alerts
Receive CRSP Data Alerts
Get market-moving data, filings, and signals for CRSP in real time.
Sign Up
$CRSP Analyst Ratings
Wall Street analysts have issued reports on $CRSP in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 02/13/2026
- Citizens issued a "Market Outperform" rating on 01/30/2026
To track analyst ratings and price targets for $CRSP, check out Quiver Quantitative's $CRSP forecast page.
$CRSP Price Targets
Multiple analysts have issued price targets for $CRSP recently. We have seen 8 analysts offer price targets for $CRSP in the last 6 months, with a median target of $78.0.
Here are some recent targets:
- William Pickering from Bernstein set a target price of $56.0 on 05/13/2026
- Yigal Nochomovitz from Citigroup set a target price of $82.0 on 05/06/2026
- Edward Tenthoff from Piper Sandler set a target price of $110.0 on 03/17/2026
- Geulah Livshits from Chardan Capital set a target price of $76.0 on 02/17/2026
- Gil Blum from Needham set a target price of $82.0 on 02/13/2026
- Tyler Van Buren from TD Cowen set a target price of $45.0 on 02/13/2026
- Liisa Bayko from Evercore ISI Group set a target price of $74.0 on 02/13/2026
You can track data on $CRSP on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Read full article here »
$CRSP stock is up 8% today. Here's what we see in our data.
$CRSP stock has now risen 8% today, according to our price data from Polygon. There has been approximately $54,230,206 of trading volume.
It has been the 627th most-searched ticker on Quiver Quantitative over the last day, out of 13,110 total tickers searched.
Here is what we see in our data on $CRSP (you can track the company live on Quiver's $CRSP stock page):
$CRSP Insider Trading Activity
$CRSP insiders have traded $CRSP stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $CRSP stock by insiders over the last 6 months:
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CRSP Hedge Fund Activity
We have seen 219 institutional investors add shares of $CRSP stock to their portfolio, and 148 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CRSP Analyst Ratings
Wall Street analysts have issued reports on $CRSP in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
To track analyst ratings and price targets for $CRSP, check out Quiver Quantitative's $CRSP forecast page.
$CRSP Price Targets
Multiple analysts have issued price targets for $CRSP recently. We have seen 8 analysts offer price targets for $CRSP in the last 6 months, with a median target of $78.0.
Here are some recent targets:
You can track data on $CRSP on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Read full article here »